tiprankstipranks
Boston Scientific (CH:BSX)
NYSE:BSX
Switzerland Market

Boston Scientific (BSX) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

BSX Analyst Ratings

Strong Buy
25Ratings
Strong Buy
22 Buy
3 Hold
0 Sell
Based on 25 analysts giving stock ratings to
Boston
Scientific
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

BSX Stock 12 Month Forecast

Average Price Target

$60.37
Based on 25 Wall Street analysts offering 12 month price targets for Boston Scientific in the last 3 months. The average price target is $60.37 with a high forecast of $81.16 and a low forecast of $44.64. The average price target represents a change from the last price of .
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
Highest Price Target$81.16Average Price Target$60.37Lowest Price Target$44.64
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus Analyst forecast on CH:BSX
Stifel Nicolaus
Stifel Nicolaus
CHF60.87CHF52.75
Buy
Reiterated
06/25/26
Boston Scientific price target lowered to $65 from $75 at StifelBoston Scientific price target lowered to $65 from $75 at Stifel
BTIG
CHF52.75
Buy
Reiterated
06/25/26
Analysts Offer Insights on Healthcare Companies: RegenXBio (NASDAQ: RGNX), Cronos Group (NASDAQ: CRON) and Boston Scientific (NYSE: BSX)
Jefferies
CHF81.16CHF54.38
Buy
Assigned
06/24/26
Boston Scientific price target lowered to $67 from $100 at JefferiesBoston Scientific price target lowered to $67 from $100 at Jefferies
TD Cowen
CHF49.51
Buy
Reiterated
06/22/26
Analysts Are Bullish on These Healthcare Stocks: Boston Scientific (BSX), Coherus Biosciences (CHRS)
Bank of America Securities Analyst forecast on CH:BSX
Bank of America Securities
Bank of America Securities
CHF55.19CHF49.51
Buy
Reiterated
06/12/26
Truist’s Travis Steed Reiterates Buy on Boston Scientific, Citing Underappreciated Watchman Upside and Maintaining $68 Price Target
Piper Sandler Analyst forecast on CH:BSX
Piper Sandler
Piper Sandler
CHF73.04CHF52.75
Buy
Reiterated
06/12/26
Boston Scientific price target lowered to $65 from $90 at Piper SandlerBoston Scientific price target lowered to $65 from $90 at Piper Sandler
Truist Financial Analyst forecast on CH:BSX
Truist Financial
Truist Financial
CHF68.99CHF51.94
Buy
Assigned
06/04/26
Boston Scientific (BSX) Receives a Buy from Truist Financial
Canaccord Genuity Analyst forecast on CH:BSX
Canaccord Genuity
Canaccord Genuity
CHF57.62CHF56.81
Buy
Reiterated
06/01/26
Boston Scientific price target lowered to $70 from $71 at CanaccordBoston Scientific price target lowered to $70 from $71 at Canaccord
Wolfe Research Analyst forecast on CH:BSX
Wolfe Research
Wolfe Research
Hold
Downgraded
05/29/26
Boston Scientific downgraded to Peer Perform from Outperform at Wolfe ResearchBoston Scientific downgraded to Peer Perform from Outperform at Wolfe Research
Citi
CHF70.61CHF56.81
Buy
Reiterated
05/29/26
Boston Scientific price target lowered to $70 from $87 at CitiBoston Scientific price target lowered to $70 from $87 at Citi
Leerink Partners Analyst forecast on CH:BSX
Leerink Partners
Leerink Partners
CHF70.61CHF60.06
Buy
Reiterated
05/28/26
Boston Scientific price target lowered to $74 from $87 at LeerinkBoston Scientific price target lowered to $74 from $87 at Leerink
Robert W. Baird Analyst forecast on CH:BSX
Robert W. Baird
Robert W. Baird
CHF60.87CHF56.81
Buy
Reiterated
05/28/26
Boston Scientific price target lowered to $70 from $75 at BairdBoston Scientific price target lowered to $70 from $75 at Baird
Barclays Analyst forecast on CH:BSX
Barclays
Barclays
CHF77.91CHF72.23
Buy
Reiterated
05/28/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Wells Fargo Analyst forecast on CH:BSX
Wells Fargo
Wells Fargo
CHF60.87CHF44.64
Hold
Downgraded
05/28/26
Boston Scientific downgraded to Equal Weight from Overweight at Wells FargoBoston Scientific downgraded to Equal Weight from Overweight at Wells Fargo
J.P. Morgan Analyst forecast on CH:BSX
J.P. Morgan
J.P. Morgan
Buy
Reiterated
05/27/26
Robbie Marcus Maintains Buy Rating on Boston Scientific Despite Near-Term WATCHMAN Headwinds, Citing Intact Long-Term Growth Outlook
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus Analyst forecast on CH:BSX
Stifel Nicolaus
Stifel Nicolaus
CHF60.87CHF52.75
Buy
Reiterated
06/25/26
Boston Scientific price target lowered to $65 from $75 at StifelBoston Scientific price target lowered to $65 from $75 at Stifel
BTIG
CHF52.75
Buy
Reiterated
06/25/26
Analysts Offer Insights on Healthcare Companies: RegenXBio (NASDAQ: RGNX), Cronos Group (NASDAQ: CRON) and Boston Scientific (NYSE: BSX)
Jefferies
CHF81.16CHF54.38
Buy
Assigned
06/24/26
Boston Scientific price target lowered to $67 from $100 at JefferiesBoston Scientific price target lowered to $67 from $100 at Jefferies
TD Cowen
CHF49.51
Buy
Reiterated
06/22/26
Analysts Are Bullish on These Healthcare Stocks: Boston Scientific (BSX), Coherus Biosciences (CHRS)
Bank of America Securities Analyst forecast on CH:BSX
Bank of America Securities
Bank of America Securities
CHF55.19CHF49.51
Buy
Reiterated
06/12/26
Truist’s Travis Steed Reiterates Buy on Boston Scientific, Citing Underappreciated Watchman Upside and Maintaining $68 Price Target
Piper Sandler Analyst forecast on CH:BSX
Piper Sandler
Piper Sandler
CHF73.04CHF52.75
Buy
Reiterated
06/12/26
Boston Scientific price target lowered to $65 from $90 at Piper SandlerBoston Scientific price target lowered to $65 from $90 at Piper Sandler
Truist Financial Analyst forecast on CH:BSX
Truist Financial
Truist Financial
CHF68.99CHF51.94
Buy
Assigned
06/04/26
Boston Scientific (BSX) Receives a Buy from Truist Financial
Canaccord Genuity Analyst forecast on CH:BSX
Canaccord Genuity
Canaccord Genuity
CHF57.62CHF56.81
Buy
Reiterated
06/01/26
Boston Scientific price target lowered to $70 from $71 at CanaccordBoston Scientific price target lowered to $70 from $71 at Canaccord
Wolfe Research Analyst forecast on CH:BSX
Wolfe Research
Wolfe Research
Hold
Downgraded
05/29/26
Boston Scientific downgraded to Peer Perform from Outperform at Wolfe ResearchBoston Scientific downgraded to Peer Perform from Outperform at Wolfe Research
Citi
CHF70.61CHF56.81
Buy
Reiterated
05/29/26
Boston Scientific price target lowered to $70 from $87 at CitiBoston Scientific price target lowered to $70 from $87 at Citi
Leerink Partners Analyst forecast on CH:BSX
Leerink Partners
Leerink Partners
CHF70.61CHF60.06
Buy
Reiterated
05/28/26
Boston Scientific price target lowered to $74 from $87 at LeerinkBoston Scientific price target lowered to $74 from $87 at Leerink
Robert W. Baird Analyst forecast on CH:BSX
Robert W. Baird
Robert W. Baird
CHF60.87CHF56.81
Buy
Reiterated
05/28/26
Boston Scientific price target lowered to $70 from $75 at BairdBoston Scientific price target lowered to $70 from $75 at Baird
Barclays Analyst forecast on CH:BSX
Barclays
Barclays
CHF77.91CHF72.23
Buy
Reiterated
05/28/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Wells Fargo Analyst forecast on CH:BSX
Wells Fargo
Wells Fargo
CHF60.87CHF44.64
Hold
Downgraded
05/28/26
Boston Scientific downgraded to Equal Weight from Overweight at Wells FargoBoston Scientific downgraded to Equal Weight from Overweight at Wells Fargo
J.P. Morgan Analyst forecast on CH:BSX
J.P. Morgan
J.P. Morgan
Buy
Reiterated
05/27/26
Robbie Marcus Maintains Buy Rating on Boston Scientific Despite Near-Term WATCHMAN Headwinds, Citing Intact Long-Term Growth Outlook
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Boston Scientific

3 Months
Success Rate
27/40 ratings generated profit
68%
Average Return
+1.87%
Copying Marie Thibault's trades and holding each position for 3 Months would result in 67.50% of your transactions generating a profit, with an average return of +1.87% per trade.
1 Year
Jayson BedfordRaymond James
Success Rate
40/54 ratings generated profit
74%
Average Return
+12.18%
Copying Jayson Bedford's trades and holding each position for 1 Year would result in 74.07% of your transactions generating a profit, with an average return of +12.18% per trade.
2 Years
Jayson BedfordRaymond James
Success Rate
42/54 ratings generated profit
78%
Average Return
+23.22%
Copying Jayson Bedford's trades and holding each position for 2 Years would result in 77.78% of your transactions generating a profit, with an average return of +23.22% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BSX Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
5
17
30
36
25
Buy
61
69
68
53
45
Hold
0
0
1
3
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
66
86
99
92
73
In the current month, BSX has received 70 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. BSX average Analyst price target in the past 3 months is 60.37.
Each month's total comprises the sum of three months' worth of ratings.

BSX Financial Forecast

BSX Earnings Forecast

Next quarter’s earnings estimate for BSX is $0.67 with a range of $0.66 to $0.68. The previous quarter’s EPS was $0.65. BSX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year BSX has Performed in-line its overall industry.
Next quarter’s earnings estimate for BSX is $0.67 with a range of $0.66 to $0.68. The previous quarter’s EPS was $0.65. BSX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year BSX has Performed in-line its overall industry.

BSX Sales Forecast

Next quarter’s sales forecast for BSX is $4.36B with a range of $4.32B to $4.40B. The previous quarter’s sales results were $4.22B. BSX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year BSX has Performed in-line its overall industry.
Next quarter’s sales forecast for BSX is $4.36B with a range of $4.32B to $4.40B. The previous quarter’s sales results were $4.22B. BSX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year BSX has Performed in-line its overall industry.

BSX Stock Forecast FAQ

What is CH:BSX’s average 12-month price target, according to analysts?
Based on analyst ratings, Boston Scientific’s 12-month average price target is 60.37.
    What is CH:BSX’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:BSX, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Boston Scientific a Buy, Sell or Hold?
        Boston Scientific has a consensus rating of Strong Buy, which is based on 22 buy ratings, 3 hold ratings and 0 sell ratings.
          What is Boston Scientific’s share price target?
          The average share price target for Boston Scientific is 60.37. This is based on 25 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $81.16 ,and the lowest forecast is $44.64. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Boston Scientific?
            Boston Scientific’s analyst rating consensus is a Strong Buy. This is based on the ratings of 25 Wall Streets Analysts.
              How can I buy shares of Boston Scientific?
              To buy shares of CH:BSX, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.